Aspen Aerogels Files 8-K for Financial Updates
Ticker: ASPN · Form: 8-K · Filed: Aug 7, 2025 · CIK: 1145986
| Field | Detail |
|---|---|
| Company | Aspen Aerogels Inc (ASPN) |
| Form Type | 8-K |
| Filed Date | Aug 7, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, regulation-fd
TL;DR
Aspen Aerogels dropped an 8-K on Aug 7th for financial and reg FD updates. Check it for the deets.
AI Summary
Aspen Aerogels, Inc. filed an 8-K on August 7, 2025, reporting on its Results of Operations and Financial Condition, and providing Regulation FD disclosures. The filing also includes Financial Statements and Exhibits. Specific financial details or operational updates were not detailed in the provided text, but the filing indicates a standard reporting event.
Why It Matters
This 8-K filing provides investors with crucial updates on Aspen Aerogels' financial performance and operational status, enabling informed investment decisions.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial reporting and does not appear to contain any immediately alarming or significant new risks.
Key Players & Entities
- Aspen Aerogels, Inc. (company) — Registrant
- August 7, 2025 (date) — Date of Report
- 001-36481 (company) — SEC File Number
- 04-3559972 (company) — I.R.S. Employer Identification No.
- 30 Forbes Road, Building B Northborough, Massachusetts 01532 (company) — Principal Executive Offices Address
- 508-691-1111 (company) — Business Phone Number
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text of the 8-K filing does not detail specific financial results or operational updates, only that the filing pertains to 'Results of Operations and Financial Condition'.
What is the exact date of the earliest event reported in this 8-K?
The date of the earliest event reported in this 8-K is August 7, 2025.
What is the company's principal executive office address?
The company's principal executive office address is 30 Forbes Road, Building B, Northborough, Massachusetts 01532.
What is the SEC file number for Aspen Aerogels, Inc.?
The SEC file number for Aspen Aerogels, Inc. is 001-36481.
What are the main items covered by this 8-K filing?
This 8-K filing covers Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits.
Filing Stats: 689 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2025-08-07 06:30:30
Filing Documents
- f8k_080725.htm (8-K) — 17KB
- exh_991.htm (EX-99.1) — 153KB
- 0001171843-25-005147.txt ( ) — 379KB
- gnw-20250101.xsd (EX-101.SCH) — 3KB
- gnw-20250101_def.xml (EX-101.DEF) — 25KB
- gnw-20250101_lab.xml (EX-101.LAB) — 35KB
- gnw-20250101_pre.xml (EX-101.PRE) — 24KB
- f8k_080725_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On August 7, 2025, Aspen Aerogels, Inc. announced its financial results for the second quarter of 2025, which ended June 30, 2025, and also discussed business developments. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1. The information set forth in the press release, except for the information set forth under the headings "Second Half of 2025 Financial Outlook," "Aspen Announces CFO Transition to Internal Successor" and "About Aspen Aerogels, Inc.," together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 2.02 of this Current Report on Form 8-K.
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. The information set forth under the headings "Second Half of 2025 Financial Outlook," "Aspen Announces CFO Transition to Internal Successor" and "About Aspen Aerogels, Inc.," together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 7.01 of this Current Report on Form 8-K.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release issued by Aspen Aerogels, Inc. on August 7, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) The press release may contain hypertext links to information on our website. The information on our website is not incorporated by reference into this Current Report on Form 8-K and does not constitute a part of this Form 8-K. The information contained in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASPEN AEROGELS, INC. Date: August 7, 2025 By: /s/ Ricardo C. Rodriguez Name: Ricardo C. Rodriguez Title: Chief Financial Officer and Treasurer